{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T04:58:48Z","timestamp":1789016328392,"version":"build-2803163510"},"reference-count":51,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,3]]},"abstract":"<jats:p>Sickle cell disease is a common genetic disorder affecting &gt;300\u2009000 people across the world. The vast majority of patients cared for in high-resource settings live well into adulthood, but many develop a high burden of disease complications. Good standard of care including disease-modifying agents and transfusion programs limits the number of patients who develop end-stage organ disease, but for those that do, the prognosis can be very poor. Solid organ transplantation is a well-established mode of treatment for patients with sickle cell disease and kidney or liver failure, but appropriate patient selection and perioperative management are important for achieving good outcomes. Hematopoietic stem cell transplantation and gene therapy may offer novel treatment options for adult patients with chronic organ damage in the future, but these are not yet widely available. For now, good, holistic care and early intervention of end-organ complications can minimize the number of patients requiring solid organ transplantation later in life.<\/jats:p>","DOI":"10.1097\/tp.0000000000004305","type":"journal-article","created":{"date-parts":[[2022,10,10]],"date-time":"2022-10-10T04:09:20Z","timestamp":1665374960000},"page":"596-604","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["An Overview of Solid Organ Transplantation in Patients With Sickle Cell Disease"],"prefix":"10.1097","volume":"107","author":[{"given":"Claire C.","family":"Sharpe","sequence":"first","affiliation":[{"name":"Department of Inflammation Biology, Faculty of Life Sciences and Medicine, King\u2019s College London, London, United Kingdom."},{"name":"Department of Renal Medicine, King\u2019s College Hospital NHS Foundation Trust, London, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abid","family":"Suddle","sequence":"additional","affiliation":[{"name":"Institute of Liver Studies, King\u2019s College Hospital NHS Foundation Trust, London, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Stuart-Smith","sequence":"additional","affiliation":[{"name":"Department of Haematology, Kings College Hospital NHS Foundation Trust, London, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,10,10]]},"reference":[{"key":"R1-20250604","doi-asserted-by":"crossref","first-page":"021103","DOI":"10.7189\/jogh.08.021103","article-title":"The global burden of sickle cell disease in children under five years of age: a systematic review and meta-analysis.","volume":"8","author":"Wastnedge","year":"2018","journal-title":"J Glob Health"},{"key":"R4-20250604","doi-asserted-by":"crossref","first-page":"S398","DOI":"10.1016\/j.amepre.2011.09.013","article-title":"Sickle cell disease in Africa: a neglected cause of early childhood mortality.","volume":"41","author":"Grosse","year":"2011","journal-title":"Am J Prev Med"},{"key":"R5-20250604","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1002\/ajh.23683","article-title":"Factors associated with survival in a contemporary adult sickle cell disease cohort.","volume":"89","author":"Elmariah","year":"2014","journal-title":"Am J Hematol"},{"key":"R6-20250604","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1182\/blood-2016-05-716910","article-title":"Survival in adults with sickle cell disease in a high-income setting.","volume":"128","author":"Gardner","year":"2016","journal-title":"Blood"},{"key":"R7-20250604","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1016\/j.annemergmed.2020.08.009","article-title":"Trends in sickle cell disease-related mortality in the United States, 1979 to 2017.","volume":"76","author":"Payne","year":"2020","journal-title":"Ann Emerg Med"},{"key":"R9-20250604","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1080\/10739680490278312","article-title":"Polymerization and sickle cell disease: a molecular view.","volume":"11","author":"Ferrone","year":"2004","journal-title":"Microcirculation"},{"key":"R10-20250604","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1172\/JCI133639","article-title":"The multifaceted role of ischemia\/reperfusion in sickle cell anemia.","volume":"130","author":"Hebbel","year":"2020","journal-title":"J Clin Invest"},{"key":"R11-20250604","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1002\/ajh.26308","article-title":"Multiple inducers of endothelial NOS (eNOS) dysfunction in sickle cell disease.","volume":"96","author":"Hebbel","year":"2021","journal-title":"Am J Hematol"},{"key":"R12-20250604","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3324\/haematol.2011.050336","article-title":"Association between hemolysis and albuminuria in adults with sickle cell anemia.","volume":"97","author":"Day","year":"2012","journal-title":"Haematologica"},{"key":"R13-20250604","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/01.md.0000189089.45003.52","article-title":"Outcome of sickle cell anemia: a 4-decade observational study of 1056 patients.","volume":"84","author":"Powars","year":"2005","journal-title":"Medicine (Baltimore)"},{"key":"R14-20250604","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/j.1751-553X.2008.01089.x","article-title":"The changing face of homozygous sickle cell disease: 102 patients over 60 years.","volume":"31","author":"Serjeant","year":"2009","journal-title":"Int J Lab Hematol"},{"key":"R15-20250604","doi-asserted-by":"crossref","first-page":"614","DOI":"10.7326\/0003-4819-115-8-614","article-title":"Chronic renal failure in sickle cell disease: risk factors, clinical course, and mortality.","volume":"115","author":"Powars","year":"1991","journal-title":"Ann Intern Med"},{"key":"R16-20250604","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/bjh.14040","article-title":"Morbidity and mortality of sickle cell disease patients starting intermittent haemodialysis: a comparative cohort study with non-sickle dialysis patients.","volume":"174","author":"Nielsen","year":"2016","journal-title":"Br J Haematol"},{"key":"R17-20250604","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1159\/000513012","article-title":"Mortality and hospitalizations among sickle cell disease patients with end-stage kidney disease initiating dialysis.","volume":"51","author":"Olaniran","year":"2020","journal-title":"Am J Nephrol"},{"key":"R18-20250604","doi-asserted-by":"crossref","first-page":"407","DOI":"10.2215\/CJN.02720320","article-title":"Mortality and access to kidney transplantation in patients with sickle cell disease-associated kidney failure.","volume":"16","author":"Bae","year":"2021","journal-title":"Clin J Am Soc Nephrol"},{"key":"R19-20250604","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.3390\/jcm10143063","article-title":"Outcomes of kidney transplant recipients with sickle cell disease: an analysis of the 2000-2019 UNOS\/OPTN database.","volume":"10","author":"Leeaphorn","year":"2021","journal-title":"J Clin Med"},{"key":"R20-20250604","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1097\/TP.0000000000002652","article-title":"A systematic review for variables to be collected in a transplant database for improving risk prediction.","volume":"103","author":"Almasri","year":"2019","journal-title":"Transplantation"},{"key":"R21-20250604","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1111\/bjh.16113","article-title":"Survival and specific outcome of sickle cell disease patients after renal transplantation.","volume":"187","author":"G\u00e9rardin","year":"2019","journal-title":"Br J Haematol"},{"key":"R22-20250604","doi-asserted-by":"crossref","first-page":"e0236998","DOI":"10.1371\/journal.pone.0236998","article-title":"Outcomes following kidney transplantation in patients with sickle cell disease: the impact of automated exchange blood transfusion.","volume":"15","author":"Willis","year":"2020","journal-title":"PLoS One"},{"key":"R23-20250604","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1111\/ajt.15233","article-title":"Shared alloimmune responses against blood and transplant donors result in adverse clinical outcomes following blood transfusion post-renal transplantation.","volume":"19","author":"Hassan","year":"2019","journal-title":"Am J Transplant"},{"key":"R24-20250604","doi-asserted-by":"crossref","first-page":"3720","DOI":"10.1182\/blood-2014-02-557439","article-title":"How I treat renal complications in sickle cell disease.","volume":"123","author":"Sharpe","year":"2014","journal-title":"Blood"},{"key":"R25-20250604","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/S0002-9343(80)80008-8","article-title":"The liver in sickle cell disease. A clinicopathologic study of 70 patients.","volume":"69","author":"Bauer","year":"1980","journal-title":"Am J Med"},{"key":"R26-20250604","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1002\/ajh.20685","article-title":"Circumstances of death in adult sickle cell disease patients.","volume":"81","author":"Darbari","year":"2006","journal-title":"Am J Hematol"},{"key":"R27-20250604","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1053\/jhep.2001.24114","article-title":"Sickle cell hepatopathy.","volume":"33","author":"Banerjee","year":"2001","journal-title":"Hepatology"},{"key":"R28-20250604","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1136\/bmj.295.6592.234","article-title":"Gall stones in sickle cell disease in the United Kingdom.","volume":"295","author":"Bond","year":"1987","journal-title":"Br Med J"},{"key":"R29-20250604","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/j.cgh.2007.08.009","article-title":"Hepatic dysfunction in sickle cell disease: a new system of classification based on global assessment.","volume":"5","author":"Berry","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R30-20250604","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1002\/lt.21031","article-title":"Liver transplantation for sickle cell hepatopathy.","volume":"13","author":"Friedman","year":"2007","journal-title":"Liver Transpl"},{"key":"R31-20250604","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1182\/hematology.2019000037","article-title":"Management of liver complications in sickle cell disease.","volume":"2019","author":"Suddle","year":"2019","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"R32-20250604","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/j.hpb.2020.12.007","article-title":"Liver transplantation for sickle cell disease: a systematic review.","volume":"23","author":"Felli","year":"2021","journal-title":"HPB (Oxford)"},{"key":"R33-20250604","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jss.2020.05.015","article-title":"Liver transplantation in patients with sickle cell disease in the United States.","volume":"255","author":"Hogen","year":"2020","journal-title":"J Surg Res"},{"key":"R34-20250604","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1111\/tri.13669","article-title":"Liver transplantation in patients with sickle cell disease: possible but challenging-a cohort study.","volume":"33","author":"Levesque","year":"2020","journal-title":"Transpl Int"},{"key":"R35-20250604","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1097\/00007890-199510150-00026","article-title":"Liver transplantation in a patient with sickle cell anemia.","volume":"60","author":"Kindscher","year":"1995","journal-title":"Transplantation"},{"key":"R36-20250604","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1097\/00007890-199505270-00025","article-title":"Liver transplantation in a child with sickle cell anemia.","volume":"59","author":"Lang","year":"1995","journal-title":"Transplantation"},{"key":"R37-20250604","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/00007890-199901150-00010","article-title":"Hepatic sickling: an unusual cause of liver allograft dysfunction.","volume":"67","author":"Lerut","year":"1999","journal-title":"Transplantation"},{"key":"R38-20250604","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1056\/NEJM199507273330402","article-title":"A comparison of conservative and aggressive transfusion regimens in the perioperative management of sickle cell disease. The Preoperative Transfusion in Sickle Cell Disease Study Group.","volume":"333","author":"Vichinsky","year":"1995","journal-title":"N Engl J Med"},{"key":"R39-20250604","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1002\/lt.22257","article-title":"Transplantation for liver failure in patients with sickle cell disease: challenging but feasible.","volume":"17","author":"Hurtova","year":"2011","journal-title":"Liver Transpl"},{"key":"R40-20250604","doi-asserted-by":"crossref","first-page":"1801913","DOI":"10.1183\/13993003.01913-2018","article-title":"Haemodynamic definitions and updated clinical classification of pulmonary hypertension.","volume":"53","author":"Simonneau","year":"2019","journal-title":"Eur Respir J"},{"key":"R41-20250604","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/MCP.0000000000000795","article-title":"The different facets of sickle cell disease-related pulmonary hypertension.","volume":"27","author":"Prohaska","year":"2021","journal-title":"Curr Opin Pulm Med"},{"key":"R42-20250604","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1182\/blood-2015-08-618561","article-title":"Pathophysiology and treatment of pulmonary hypertension in sickle cell disease.","volume":"127","author":"Gordeuk","year":"2016","journal-title":"Blood"},{"key":"R43-20250604","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1086\/674749","article-title":"First successful lung transplantation for sickle cell disease with severe pulmonary arterial hypertension and pulmonary veno-occlusive disease.","volume":"3","author":"George","year":"2013","journal-title":"Pulm Circ"},{"key":"R45-20250604","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/bjh.14346","article-title":"Guidelines on red cell transfusion in sickle cell disease. Part I: principles and laboratory aspects.","volume":"176","author":"Davis","year":"2017","journal-title":"Br J Haematol"},{"key":"R46-20250604","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/bjh.17839","article-title":"Guidelines for the monitoring and management of iron overload in patients with haemoglobinopathies and rare anaemias.","volume":"196","author":"Shah","year":"2022","journal-title":"Br J Haematol"},{"key":"R47-20250604","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1182\/blood-2009-05-221333","article-title":"The effect of prolonged administration of hydroxyurea on morbidity and mortality in adult patients with sickle cell syndromes: results of a 17-year, single-center trial (LaSHS).","volume":"115","author":"Voskaridou","year":"2010","journal-title":"Blood"},{"key":"R48-20250604","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1002\/pbc.24100","article-title":"Effect of hydroxyurea treatment on renal function parameters: results from the multi-center placebo-controlled BABY HUG clinical trial for infants with sickle cell anemia.","volume":"59","author":"Alvarez","year":"2012","journal-title":"Pediatr Blood Cancer"},{"key":"R49-20250604","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1111\/bjh.17663","article-title":"Early initiation of hydroxyurea (hydroxycarbamide) using individualised, pharmacokinetics-guided dosing can produce sustained and nearly pancellular expression of fetal haemoglobin in children with sickle cell anaemia.","volume":"194","author":"Quinn","year":"2021","journal-title":"Br J Haematol"},{"key":"R50-20250604","doi-asserted-by":"crossref","first-page":"e0141706","DOI":"10.1371\/journal.pone.0141706","article-title":"Hydroxyurea-increased fetal hemoglobin is associated with less organ damage and longer survival in adults with sickle cell anemia.","volume":"10","author":"Fitzhugh","year":"2015","journal-title":"PLoS One"},{"key":"R51-20250604","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1111\/bjh.17311","article-title":"Non-myeloablative human leukocyte antigen-matched related donor transplantation in sickle cell disease: outcomes from three independent centres.","volume":"192","author":"Alzahrani","year":"2021","journal-title":"Br J Haematol"},{"key":"R52-20250604","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s00277-017-2936-7","article-title":"Haploidentical hematopoietic bone marrow transplantation followed by living kidney transplantation from the same donor in a sickle cell disease patient with end-stage renal failure.","volume":"96","author":"Knuppel","year":"2017","journal-title":"Ann Hematol"},{"key":"R53-20250604","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1056\/NEJMoa2117175","article-title":"Biologic and clinical efficacy of LentiGlobin for sickle cell disease.","volume":"386","author":"Kanter","year":"2022","journal-title":"N Engl J Med"},{"key":"R54-20250604","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1056\/NEJMoa1611770","article-title":"Crizanlizumab for the prevention of pain crises in sickle cell disease.","volume":"376","author":"Ataga","year":"2017","journal-title":"N Engl J Med"},{"key":"R55-20250604","doi-asserted-by":"crossref","first-page":"e323","DOI":"10.1016\/S2352-3026(21)00059-4","article-title":"Voxelotor in adolescents and adults with sickle cell disease (HOPE): long-term follow-up results of an international, randomised, double-blind, placebo-controlled, phase 3 trial.","volume":"8","author":"Howard","year":"2021","journal-title":"Lancet Haematol"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000004305","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T18:18:24Z","timestamp":1749061104000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000004305"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,10]]},"references-count":51,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000004305","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10,10]]}}}